(Q70240417)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

1 reference

K S Barron

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

D A Person

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

E J Brewer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

M G Beale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

A M Robson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

language of work or name

English

0 references

publication date

1 July 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

137-141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

The clinical course of the proliferative and membranous forms of lupus nephritis.

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Lupus nephritis. Clinical course as related to morphologic forms and their transitions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

NIH conference. Systemic lupus erythematosus: evolving concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

The treatment of lupus nephritis by methyl prednisolone pulse therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Serum immune complexes and disease activity in lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

7 January 2021

Antivascular antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Systemic lupus erythematosus within the first two decades of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Pulse methylprednisolone therapy in idiopathic, rapidly progressive glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

High-dose methylprednisolone pulses in active lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

Lupus nephropathy without clinical renal involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

inferred from DOI database lookup

7 January 2021

based on heuristic

“Pulse” methylprednisolone therapy in the treatment of severe glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980203-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(82)80203-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7045314%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference